[go: up one dir, main page]

EA201170526A1 - Тиазолилпиразолопиримидины в качестве синтетических промежуточных соединений и связанные с ними способы синтеза - Google Patents

Тиазолилпиразолопиримидины в качестве синтетических промежуточных соединений и связанные с ними способы синтеза

Info

Publication number
EA201170526A1
EA201170526A1 EA201170526A EA201170526A EA201170526A1 EA 201170526 A1 EA201170526 A1 EA 201170526A1 EA 201170526 A EA201170526 A EA 201170526A EA 201170526 A EA201170526 A EA 201170526A EA 201170526 A1 EA201170526 A1 EA 201170526A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tiazolylpyrazolopyrimidines
synthetic intermediate
synthesis methods
intermediate compounds
related synthesis
Prior art date
Application number
EA201170526A
Other languages
English (en)
Other versions
EA018807B1 (ru
Inventor
Джон Роберт Риззо
Сатхиш Кумар Боини
Радхе Кришан Ваид
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201170526A1 publication Critical patent/EA201170526A1/ru
Publication of EA018807B1 publication Critical patent/EA018807B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к синтетическому промежуточному соединению формулыи его применению в способе синтеза для получения соединений формулы
EA201170526A 2008-10-02 2009-09-29 Тиазолилпиразолопиримидины в качестве синтетических промежуточных соединений и связанные с ними способы синтеза EA018807B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10215308P 2008-10-02 2008-10-02
PCT/US2009/058722 WO2010039678A1 (en) 2008-10-02 2009-09-29 Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes

Publications (2)

Publication Number Publication Date
EA201170526A1 true EA201170526A1 (ru) 2011-10-31
EA018807B1 EA018807B1 (ru) 2013-10-30

Family

ID=41507435

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170526A EA018807B1 (ru) 2008-10-02 2009-09-29 Тиазолилпиразолопиримидины в качестве синтетических промежуточных соединений и связанные с ними способы синтеза

Country Status (21)

Country Link
US (1) US8563718B2 (ru)
EP (1) EP2350079B1 (ru)
JP (1) JP5524221B2 (ru)
KR (1) KR101357392B1 (ru)
CN (1) CN102171212A (ru)
AR (1) AR073708A1 (ru)
AU (1) AU2009298757B2 (ru)
BR (1) BRPI0920838A2 (ru)
CA (1) CA2739422C (ru)
CY (1) CY1113499T1 (ru)
DK (1) DK2350079T3 (ru)
EA (1) EA018807B1 (ru)
ES (1) ES2397509T3 (ru)
HR (1) HRP20120961T1 (ru)
IL (1) IL211292A (ru)
MX (1) MX2011003529A (ru)
PL (1) PL2350079T3 (ru)
PT (1) PT2350079E (ru)
SI (1) SI2350079T1 (ru)
TW (1) TWI432435B (ru)
WO (1) WO2010039678A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019015320A (es) 2017-08-14 2020-07-20 Spruce Biosciences Inc Antagonistas del receptor del factor liberador de corticotropina.
CA3064445A1 (en) * 2017-08-14 2019-02-21 Spruce Biosciences, Inc. Corticotropin releasing factor receptor antagonists
KR20240023691A (ko) 2020-08-12 2024-02-22 스프루스 바이오사이언시스 인코포레이티드 다낭성 난소 증후군을 치료하기 위한 방법 및 조성물
US11708372B2 (en) 2021-11-19 2023-07-25 Spruce Biosciences, Inc. Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643938A (en) * 1992-06-10 1997-07-01 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compounds for the treatment of anemia
ATE481405T1 (de) * 2006-09-20 2010-10-15 Lilly Co Eli Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors
US8952207B2 (en) 2007-09-11 2015-02-10 The University Of Houston System Copper-catalyzed C—H bond arylation

Also Published As

Publication number Publication date
KR20110063513A (ko) 2011-06-10
US8563718B2 (en) 2013-10-22
DK2350079T3 (da) 2012-12-17
TWI432435B (zh) 2014-04-01
PL2350079T3 (pl) 2013-03-29
WO2010039678A1 (en) 2010-04-08
HRP20120961T1 (hr) 2012-12-31
ES2397509T3 (es) 2013-03-07
MX2011003529A (es) 2011-04-21
BRPI0920838A2 (pt) 2018-10-16
CA2739422A1 (en) 2010-04-08
SI2350079T1 (sl) 2013-02-28
US20110166345A1 (en) 2011-07-07
AR073708A1 (es) 2010-11-24
PT2350079E (pt) 2012-12-20
JP5524221B2 (ja) 2014-06-18
AU2009298757B2 (en) 2013-08-01
CN102171212A (zh) 2011-08-31
AU2009298757A1 (en) 2010-04-08
TW201018692A (en) 2010-05-16
EP2350079A1 (en) 2011-08-03
CY1113499T1 (el) 2016-06-22
CA2739422C (en) 2013-03-12
EA018807B1 (ru) 2013-10-30
IL211292A0 (en) 2011-04-28
IL211292A (en) 2013-06-27
KR101357392B1 (ko) 2014-02-03
JP2012504626A (ja) 2012-02-23
EP2350079B1 (en) 2012-11-14

Similar Documents

Publication Publication Date Title
CY1119345T1 (el) Μακροκυκλικες ενωσεις ως αναστολεις κινασης trk
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
EA201270254A1 (ru) Производные 5-фторпиримидинона
UY34825A (es) Síntesis de compuestos heterocíclicos
AR075291A1 (es) Proceso para la preparcion de derivados de l-alanina protegidos
ECSP12011581A (es) Inhibidores de bace
CR20120121A (es) Compuestos de benzoxazepina como inhibidores de la pi3k y métodos de uso
CR11776A (es) Inhibidores de bace
MA32551B1 (fr) Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires
EA200900945A1 (ru) Новый способ синтеза агомелатина
ECSP099818A (es) Procesos para la preparacion de pirazoles
CR20140237A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
CY1112829T1 (el) Νεα μεθοδος συνθεσης για την αγομελατινη
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
IL232951A0 (en) Antibodies against the her3 receptor that bind to its domain ii
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA201000257A1 (ru) Новый способ синтеза (7-метокси-l-нафтил) ацетонитрила и применение в синтезе агомелатина
IN2012DN00369A (ru)
EA201270253A1 (ru) Производные n1-ацил-5-фторпиримидинона
IN2014KN01062A (ru)
UA106886C2 (uk) Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та проміжні сполуки магнію
EA201170526A1 (ru) Тиазолилпиразолопиримидины в качестве синтетических промежуточных соединений и связанные с ними способы синтеза

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU